Vivos Therapeutics, Inc. (VVOS): Total Assets
$25.15M
As of 2025-12-31
$24.14M
As of 2026-06-30
+22.4%
3-year compound annual growth
-0.1%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $25.15M | +64.6% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $15.28M | +42.4% | 2026-04-15, Balance as of period end |
| 2023-12-31 | $10.73M | -21.8% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $13.72M | -59.3% | 2024-07-30, Balance as of period end |
| 2021-12-31 | $33.69M | +33.0% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $25.33M | +235.4% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $7.55M | n/a | 2021-03-25, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $25.15M | +64.6% |
| Nephros Inc (NEPH) | 2025-12-31 | $13.64M | +21.7% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $77.47M | +10.3% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $6.45M | +14.3% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $13.96M | +1.9% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | $21.41M | +77.0% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $15.77M | -51.9% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $110.08M | -7.4% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $69.70M | -10.6% |
Compare VVOS, NEPH, PROF, BTCY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗